Assura Plc (LON:AGR - Get Free Report) insider Ed Smith sold 50,486 shares of Assura stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of GBX 49 ($0.66), for a total transaction of £24,738.14 ($33,470.63).
Ed Smith also recently made the following trade(s):
- On Wednesday, August 13th, Ed Smith sold 116,163 shares of Assura stock. The stock was sold at an average price of GBX 49 ($0.66), for a total transaction of £56,919.87 ($77,012.41).
Assura Trading Down 3.3%
Assura stock traded down GBX 1.62 ($0.02) during mid-day trading on Thursday, reaching GBX 47.78 ($0.65). 8,874,574 shares of the company traded hands, compared to its average volume of 28,424,658. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The firm's 50 day moving average price is GBX 49.83 and its 200 day moving average price is GBX 46.97. The firm has a market capitalization of £1.56 billion, a price-to-earnings ratio of -45.67, a P/E/G ratio of 3.60 and a beta of 0.37. Assura Plc has a 52-week low of GBX 35.24 ($0.48) and a 52-week high of GBX 50.95 ($0.69).
Assura (LON:AGR - Get Free Report) last issued its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. On average, analysts anticipate that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.